Anabolic Androgenic Steroid Use as a Cause of Fulminant Heart Failure
| Autor: | Erin E Brennan, Matthew R. White, Kevin Yi Mi Ren, Mei Shi, Amar Thakrar |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Adult
Male medicine.medical_specialty Anabolism Fulminant medicine.medical_treatment Biopsy Magnetic Resonance Imaging Cine 030204 cardiovascular system & hematology 03 medical and health sciences Electrocardiography 0302 clinical medicine Anabolic Agents Internal medicine medicine Humans Testosterone Heart Failure business.industry Dilated cardiomyopathy Boldenone medicine.disease Drug Combinations Echocardiography Heart failure Acute Disease Cardiology Androgens Steroids Differential diagnosis Cardiology and Cardiovascular Medicine business 030217 neurology & neurosurgery Anabolic steroid medicine.drug |
| Zdroj: | The Canadian journal of cardiology. 34(10) |
| ISSN: | 1916-7075 |
| Popis: | A 39-year-old male weightlifter presented in fulminant heart failure. An echocardiogram revealed severe global biventricular failure. Left ventricular (LV) systolic function was estimated at 15%. His dilated cardiomyopathy was attributed to his use of both testosterone and boldenone in the 3-month period before his presentation. Although the deleterious effects of androgenic- anabolic steroids on diastolic function are well known, the effects of these drugs on systolic function is an area of ongoing investigation. Our case suggests that androgenic anabolic steroid use should be considered in the differential diagnosis of patients presenting with acute heart failure. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect